BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11356007)

  • 1. Signaling domains of the interleukin 2 receptor.
    Gaffen SL
    Cytokine; 2001 Apr; 14(2):63-77. PubMed ID: 11356007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.
    Pillet AH; Lavergne V; Pasquier V; Gesbert F; Thèze J; Rose T
    J Mol Biol; 2010 Nov; 403(5):671-92. PubMed ID: 20816854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
    Wang X; Rickert M; Garcia KC
    Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctions in lymphocyte responses to IL-2 and IL-15 reflect differential ligand binding interactions with the IL-2Rbeta chain and suggest differential roles for the IL-2Ralpha and IL-15Ralpha subunits.
    de Jong JL; Farner NL; Sondel PM
    Cytokine; 1998 Dec; 10(12):920-30. PubMed ID: 10049515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine anti-human common gamma chain monoclonal antibody CP.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor.
    Baker DP; Whitty A; Zafari MR; Olson DL; Hession CA; Miatkowski K; Avedissian LS; Foley SF; McKay ML; Benjamin CD; Burkly LC
    Biochemistry; 1998 Oct; 37(41):14337-49. PubMed ID: 9772159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit.
    Lindemann MJ; Benczik M; Gaffen SL
    J Biol Chem; 2003 Mar; 278(12):10239-49. PubMed ID: 12525482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
    Imbert V; Rezzonico R; Reichenbach P; Nabholz M
    Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling.
    Eicher DM; Waldmann TA
    J Immunol; 1998 Nov; 161(10):5430-7. PubMed ID: 9820518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera.
    Sogo T; Kawahara M; Ueda H; Otsu M; Onodera M; Nakauchi H; Nagamune T
    Cytokine; 2009 Apr; 46(1):127-36. PubMed ID: 19223197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding by the IL-2 receptor is modulated by intracellular determinants of the IL-2 receptor beta-chain.
    Goldsmith MA; Amaral MC; Greene WC
    J Immunol; 1995 Mar; 154(5):2033-40. PubMed ID: 7868880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its alpha, beta, and gamma(c) receptors.
    Rickert M; Boulanger MJ; Goriatcheva N; Garcia KC
    J Mol Biol; 2004 Jun; 339(5):1115-28. PubMed ID: 15178252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional characterization of artificial mutants of interleukin-2 receptor.
    Kondo S; Kinoshita M; Shimizu A; Saito Y; Konishi M; Sabe H; Honjo T
    Nature; 1987 May 7-13; 327(6117):64-7. PubMed ID: 3106825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor heterotrimer complex and intracellular signaling.
    Nakamura M; Asao H; Takeshita T; Sugamura K
    Semin Immunol; 1993 Oct; 5(5):309-17. PubMed ID: 8260647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
    Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
    J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
    Conrad DM; Hanniman EA; Watson CL; Mader JS; Hoskin DW
    J Cell Biochem; 2004 May; 92(2):387-99. PubMed ID: 15108363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.
    Olejniczak K; Kasprzak A
    Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction.
    Hayashi RJ; Kanagawa O
    Int Immunol; 2006 May; 18(5):645-51. PubMed ID: 16574670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of interleukin-2 complexed with its alpha receptor.
    Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
    Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.